IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice

Journal of Investigative Dermatology

Volumn 127, Issue 5, 2007, Pages 1167-1174

  Zone, John J ^a   Taylor, Ted ^a   Hull, Christopher ^a   Schmidt, Linda ^a,b   Meyer, Laurence ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BULLOUS PEMPHIGOID ANTIGEN; IMMUNOGLOBULIN E; TRINITROPHENYL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLISTER; BULLOUS PEMPHIGOID; CELL INFILTRATION; CONTROLLED STUDY; DEGRANULATION; EOSINOPHIL; ERYTHEMA; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOPATHOLOGY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SCRATCHING; SKIN GRAFT; SKIN INFLAMMATION; TISSUE SECTION; TUMOR GROWTH;

ANIMALS; AUTOANTIGENS; BASEMENT MEMBRANE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; EOSINOPHILS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, SCID; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; SKIN; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 34247248296     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700681     Document Type: Article

References (36)

1. Anhalt GJ, Diaz LA (1987) Animal models for bullous pemphigoid. Clin Dermatol 5:117-25
2. Arbesman CE, Wypych JI, Reisman RE, Beutner EH (1974) IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch Dermatol 110:378-81
3. Borradori L, Bernard P (2003) Pemphigoid group. First edn Mosby: London, pp 463-477
4. Bowszyc-Dmochowska M, Dmochowski M (2002) Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts. J Med 33:189-98
5. Cho SH, Tam SW, Demissie-Sanders S, Filler SA, Oh CK (2000) Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol 165:3154-61
6. Christofidou-Solomidou M, Longley BJ, Whitaker-Menezes D, Albelda SM, Murphy GF (1997) Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. J Invest Dermatol 109:102-7
7. Christophoridis S, Budinger L, Borradori L, Hunziker T, Merk HF, Hertl M (2000) IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol 143:349-55
8. Delaporte E, Dubost-Brama A, Ghohestani R, Nicolas JF, Neyrinck JL, Bergoend H et al. (1996) IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol 157:3642-7
9. Diaz LA, Ratrie H III, Saunders WS, Futamura S, Squiquera HL, Anhalt GJ et al. (1990) Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 86:1088-94
10. Dimson OG, Giudice GJ, Fu CL, Van den Bergh F, Warren SJ, Janson MM et al. (2003) Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120:784-8
11. Fairley JA, Fu CL, Giudice GJ (2005) Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J Invest Dermatol 125:467-72
12. Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243-50
13. Gronneberg R, Strandberg K (1985) Effect of betamethasone on the dual reaction to anti-human IgE in man: influence of time interval between administration of drug and anti-IgE. Allergy 40:223-8
14. Haak-Frendscho M, Ridgway J, Shields R, Robbins K, Gorman C, Jardieu P (1993) Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo. J Immunol 151:351-8
15. Hakimi J, Seals C, Kondas JA, Pettine L, Danho W, Kochan J (1990) The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding. J Biol Chem 265:22079-81
16. Haneberg B, Kendall D, Apter FM, Neutra MR (1997) Distribution of monoclonal antibodies in intestinal and urogenital secretions of mice bearing hybridoma 'backpack' tumours. Scand J Immunol 45:151-9
17. Inaoki M, Sato S, Takehara K (2004) Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE. J Dermatol Sci 35:53-9
18. Ishiko A, Shimizu H, Masunaga T, Yancey K, Giudice G, Zone J et al. (1998) 97-kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxy terminal domains of the 180-kDa bullous pemphigoid antigen. J Invest Dermatol 111:93-6
19. Ishizaka T, Dvorak AM, Conrad DH, Niebyl JR, Marquette JP, Ishizaka K (1985) Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells. J Immunol 134:532-40
20. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA et al. (1993) A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480-8
21. Meyer LJ, Taylor TB, Kadunce DP, Thuong-Nguyen V, Zone JJ (1991) Bullous pemphigoid antigens: extraction and degradation of antigens during epidermal preparation. J Invest Dermatol 96:991-3
22. Meyer LJ, Taylor TB, Kadunce DP, Zone JJ (1990) Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies. J Invest Dermatol 94:611-6
23. Mita H, Yasueda H, Ishii T, Akiyama K (1995) IgE-mediated basophil releasability is influenced by intrinsic factors and by IgE on the cell surface. Allergy 50:952-8
24. Paizi M, Zivion D, Spira G (1995) Use of mutagens to increase rate of immunoglobulin isotype switching of hybridoma cells. Hybridoma 14:85-90
25. Seitzer U, Bussler H, Kullmann B, Petersen A, Becker WM, Ahmed J (2005) Mouse strain specificity of the IgE response to the major allergens of Phleum pratense. Int Arch Allergy Immunol 136:347-55
26. Shimizu H, Takizawa Y, Pulkkinen L, Zone JJ, Matsumoto K, Saida T et al. (1998) The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1. J Invest Dermatol 111:887-92
27. Sitaru C, Schmidt E, Petermann S, Munteanu LS, Brocker EB, Zillikens D (2002) Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 118:664-71
28. Spira G, Paizi M, Mazar S, Nussbaum G, Mukherjee S, Casadevall A (1996) Generation of biologically active anti-Cryptococcus neoformans IgG, IgE and IgA isotype switch variant antibodies by acridine orange mutagenesis. Clin Exp Immunol 105:436-42
29. Tanaka T, Parry DA, Klaus-Kovtun V, Steinert PM, Stanley JR (1991) Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem 266:12555-9
30. Verraes S, Hornebeck W, Polette M, Borradori L, Bernard P (2001) Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol 117:1091-6
31. Winner L III, Mack J, Weltzin R, Mekalanos JJ, Kraehenbuhl JP, Neutra MR (1991) New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun 59:977-82
32. Zone JJ, Egan CA, Taylor TB, Meyer LJ (2004) IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 9:47-51
33. Zone JJ, Pazderka Smith E, Powell D, Taylor TB, Smith JB, Meyer LJ (1994) Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA. Dermatology 189(Suppl 1):64-6
34. Zone JJ, Taylor TB, Kadunce DP, Chorzelski TP, Schachner LA, Huff JC et al. (1996) IgA antibodies in chronic bullous disease of childhood react with a 97 kDa basement membrane zone protein. J Invest Dermatol 106:1277-80
35. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ (1990) Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 85:812-20
36. Zone JJ, Taylor TB, Meyer LJ, Petersen MJ (1998) The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 110:207-10